Slika omota

Study of cardiovascular eligibility for hormonal contraception in women in Porto-Novo

<p>Introduction: The aim of this study was to determine the cardiovascular eligibility rate for hormonal contraception among women in Porto-Novo, with reference to the criteria defined by the World Health Organization (WHO).</p><p>Materials and methods: A descriptive cross-sectiona...

Spremljeno u:

Bibliografski detalji
Glavni autori:	Arnaud Sonou (Autor), Richard Aniglé (Autor), Corine Houehanou (Autor), Armand Wanvoègbè (Autor), Mathieu Ogoudjobi (Autor), Dèdonougbo Martin Houénassi (Autor)
Format:	Knjiga
Izdano:	Archives of Clinical Hypertension - Peertechz Publications, 2020-04-24.
Teme:	Research Article
Online pristup:	Connect to this object online.
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti

Medical eligibility criteria for contraceptive use
od: Ma. del Carmen Cravioto Galindo
Izdano: (2016)

The paradigm for cardiovascular effects of hormonal contraceptives
od: Zsuzsanna Ilona Katalin de Jármy Di Bella
Izdano: (2018)

Feasibility of a cardiovascular cohort in a Sub-Saharan Africa community: preliminary report of the pilot project TAHES (Tanvè Health Study) in Benin
od: Yessito Corine Houehanou, i dr.
Izdano: (2017)

Medical eligibility criteria for using various methods of contraception
od: V N Prilepskaya, i dr.
Izdano: (2014)

Acceptability of Contraceptive Methods among Urban Eligible Couples of Imphal, Manipur
od: Singh RK, i dr.
Izdano: (2004)

New contraceptive eligibility checklists for provision of combined oral contraceptives and depot-medroxyprogesterone acetate in community-based programmes
od: Amanda Stang, i dr.
Izdano: (2000)

Uso seguro de anticoncepcionais hormonais injetáveis segundo critérios médicos de elegibilidade / Safe use of injectable hormonal contraceptives according to medical eligibility criteria
od: Ana Gesselena da Silva Farias, i dr.
Izdano: (2018)

Uso seguro de anticoncepcionais hormonais injetáveis segundo critérios médicos de elegibilidade / Safe use of injectable hormonal contraceptives according to medical eligibility criteria
od: Ana Gesselena da Silva Farias, i dr.
Izdano: (2018)

Uso seguro de anticoncepcionais hormonais injetáveis segundo critérios médicos de elegibilidade / Safe use of injectable hormonal contraceptives according to medical eligibility criteria
od: Ana Gesselena da Silva Farias, i dr.
Izdano: (2018)

Uso seguro de anticoncepcionais hormonais injetáveis segundo critérios médicos de elegibilidade / Safe use of injectable hormonal contraceptives according to medical eligibility criteria
od: Ana Gesselena da Silva Farias, i dr.
Izdano: (2018)

Contraceptive Practices among the Eligible Couples from a Rural and an Urban Area of Karnataka
od: Niranjan V Gummaraj, i dr.
Izdano: (2018)

Disparities in effective contraceptive use in the United States among individuals dually eligible for Medicare and Medicaid
od: Maria I. Rodriguez, MD, MPH, i dr.
Izdano: (2023)

Medical sequencing of de novo ectodermal dysplasia in identical twins and evaluation of the potential eligibility for recombinant EDA therapy
od: Adriana Modesto, i dr.
Izdano: (2017)

Modern hormonal contraceptives
od: -
Izdano: (2017)

Personification of hormonal contraception
od: L Yu Karakhalis, i dr.
Izdano: (2016)

Venous thrombosis and hormonal contraception: what's new with estradiol-based hormonal contraceptives?
od: Fruzzetti F, i dr.
Izdano: (2018)

National medical eligibility criteria for contraceptive use 2023: focus on women's reproductive health: A review
od: Elena N. Andreeva, i dr.
Izdano: (2023)

Effect of hormonal contraceptives on lipid profile and the risk indices for cardiovascular disease in a Ghanaian community
od: Asare GA, i dr.
Izdano: (2014)

Personal selection of hormonal contraception
od: I V Kuznetsova
Izdano: (2017)

Personified choice of hormonal contraception
od: L Yu Karakhalis
Izdano: (2018)

COVID-19 and hormonal contraception
od: Angelo Cagnacci, i dr.
Izdano: (2022)

Hormonal contraception: choice algorithm
od: A.A. Olina, i dr.
Izdano: (2019)

Cross-Sectional Analyses of Social Determinants of Contraceptive Use among Eligible Couples, Rural Ujjain, Madhya Pradesh
od: Shikha Sharma, i dr.
Izdano: (2017)

Emergency hormonal contraception (literature review)
od: V N Prilepskaya, i dr.
Izdano: (2017)

Use of outpatient care in VA and Medicare among disability-eligible and age-eligible veteran patients
od: Liu Chuan-Fen, i dr.
Izdano: (2012)

Pharmacist-Prescribed Hormonal Contraception: Does Didactic Hormonal Contraception Education Affect Student Pharmacist Perceptions of This Professional Activity?
od: Rachel Rikard, i dr.
Izdano: (2021)

Estudo de Mercado sobre a Aceitação de um Novo Sabonete de Vinho do Porto
od: Raquel Guiné, i dr.
Izdano: (2016)

Important questions to ask when choosing hormonal contraception. Myths about contraception
od: Vera N. Prilepskaya, i dr.
Izdano: (2021)

Hormonal Contraceptive Use in Football Codes in Australia
od: Anthea C. Clarke, i dr.
Izdano: (2021)

Prolonged schemes of combined hormonal contraceptives assignment
od: V V Korennaya, i dr.
Izdano: (2015)

Hormonal contraception with desogestrel-induced medication use
od: S A Levakov, i dr.
Izdano: (2014)

Needs, expectations and doubt users of hormonal contraceptives
od: Galina B. Dikke
Izdano: (2020)

Female sexual function and hormonal contraception (review)
od: N N Stenyaeva, i dr.
Izdano: (2013)

Clinical Pharmacology of Hormonal Emergency Contraceptive Pills
od: Celia M. J. Matyanga, i dr.
Izdano: (2018)

The Potential of Hormonal Contraception to Influence Female Sexuality
od: Filipa de Castro Coelho, i dr.
Izdano: (2019)

Hormonal contraception in terms of effect on the hemostasis system
od: E.G. Kudinova
Izdano: (2023)

Market Diffusion of Extended Cycle Hormonal Contraceptives
od: Megen Leeds Schumacher, i dr.
Izdano: (2012)

Positif Correlation of Hormonal Contraception and The Occurrence of Leucorrhoea
od: Mirza Aulia Cahyani, i dr.
Izdano: (2023)

Market Diffusion of Extended Cycle Hormonal Contraceptives
od: Megen Leeds Schumacher, Pharm.D, i dr.
Izdano: (2012)

Drafting eligible biotech and immunotherapy claims
od: Shyh-Jen Wang
Izdano: (2019)